Dose-Intense Cyclophosphamide and Etoposide for Patients with Refractory or High-Risk Non-Hodgkin's Lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dose-Intense Cyclophosphamide and Etoposide for Patients with Refractory or High-Risk Non-Hodgkin's Lymphoma

Published:2004-09 Issue:2 Volume:5 Page:116-122
ISSN:1526-9655
Container-title:Clinical Lymphoma
language:en
Short-container-title:Clinical Lymphoma

Author:

Talbot Jeffrey,Ibom Valerie K.,Rizzieri David A.,Barrier Robert,Niedzwieki Donna,DeCastro Carlos M.,Moore Joseph O.,Buckley Patrick,Laney Rhonda,Stevenson Diane,Brumbaugh Heather,Gockerman Jon P.

Publisher

Elsevier BV

Subject

Cancer Research

Reference29 articles.

1. Autologous hematopoietic stem cell transplantation in intermediate and high grade non-Hodgkin's lymphoma: a review;Gisselbrecht;Ann Oncol,1993

2. A phase II trial of mesna/ifosphamide, mitoxantrone and etoposide for refractory lymphomas;Rodriguez;Ann Oncol,1995

3. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high-grade non-Hodgkin's lymphoma;Philip;N Engl J Med,1987

4. Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non- Hodgkin's lymphoma: value of augmented preparative regimes. A Southwest Oncology Group trial;Stiff;J Clin Oncol,1998

5. High-dose chemotherapy and hematopoietic stem cell trans- plantation for relapsed or refractory diffuse large cell non-Hodgkin's lymphoma;Vose;Ann Oncol,1998

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Awareness in Hematological Oncology;Hematological Oncology;2005-09-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP